FINWIRES · TerminalLIVE
FINWIRES

SinoPac Upgrades Bora Pharmaceuticals to Buy from Neutral; Price Target is NT$537

By

Bora Pharmaceuticals (TPE:6472) has an average rating of overweight and mean price target of NT$496.86, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles